What Changed
- ESMA launched a public consultation on updated disclosure guidelines with responses open until 9 November 2026 and final release expected in Q2 2027.
- ESMA finalised Guidelines on product supplements introducing new securities, which will apply upon publication of all official EU language translations.
- ESMA submitted draft RTS updating summary key financial information under Commission Delegated Regulation 2019/979 to the European Commission for adoption.
Issuers, financial advisers, and capital market participants operating within the European Union face updated regulatory expectations following a comprehensive package of materials published by the European Securities and Markets Authority (ESMA) under the Prospectus Regulation. Released to reflect changes introduced by the EU Listing Act, the measures aim to promote supervisory convergence, simplify existing frameworks, and reduce administrative burdens for market actors.
The package published by ESMA comprises four key components:
1. **Consultation Paper on Disclosure Requirements:** ESMA is seeking stakeholder feedback on updates to the Guidelines on disclosure requirements. The proposed updates aim to help issuers and advisers understand expected disclosures under the revised Prospectus Regulation while streamlining guidance by removing unnecessary content. The consultation deadline is 9 November 2026, with the Final Report and updated Guidelines expected in Q2 2027.
2. **Final Report on Product Supplements:** ESMA has finalised Guidelines for supplements that introduce new securities to a base prospectus. These Guidelines establish a common methodology for national competent authorities and provide market participants with greater certainty when submitting product supplements. The Guidelines will apply once translations into all official EU languages are published.
3. **Final Report on Regulatory Technical Standards (RTS):** ESMA has submitted a Final Report to the European Commission proposing updated RTS for key financial information in prospectus summaries. The RTS align summary requirements with the revised framework under the Listing Act to foster proportionate disclosure. The Commission will decide whether to adopt the RTS to update Commission Delegated Regulation 2019/979.
4. **Updated Q&As:** ESMA has revised its Prospectus Regulation Q&As to adjust legal references, provide further clarifications, and remove obsolete material, supported by an overview explaining the rationale behind the changes.
For cross-border businesses and international issuers seeking to raise capital or list securities in the EU, these measures clarify disclosure standards, enhance procedural predictability across Member States, and streamline prospectus supplement procedures.
Who May Be Affected
Issuers, advisers, financial market participants, and national competent authorities across European Union capital markets.
Cross-Border Context
Applies to both domestic EU entities and non-EU companies seeking to issue securities, publish base prospectus supplements, or prepare summaries for public offerings or listings within the European Union.
What to check next
- Monitor the European Commission's adoption decision regarding the draft RTS updating Commission Delegated Regulation 2019/979.
- Track the publication of official EU language translations for the Guidelines on product supplements to determine their application date.
- Review the overview document for updated Q&As on ESMA's portal prior to submitting consultation responses by 9 November 2026.
This article provides general information and does not constitute legal advice. Consult the official text and obtain advice appropriate to your circumstances where needed.
Prepared automatically with AI assistance from the official sources linked on this page. Translations and explanations do not replace the official text.